Page 39 - Kirin Holdings Case Study
P. 39

Appendix 3



               R&D Strategy









































               “We will consolidate Kirin Group technologies to form new businesses in the food &
               beverages domain, pharmaceuticals domain, and “bridging Pharmaceuticals and Food &
               Beverages” where we will create new value that contributes to solving social issues around
               the world.”

               Source: Kirin Report 2019 (5)
   34   35   36   37   38   39   40   41   42   43   44